Applying in vitro experiments using clinical cancer tissues and cancer cell lines, we observed that overexpression of the lncRNA MALAT1 in EOC cells encouraged drug resistance, invasion, and migration through adaptive remodeling strategies that promote tumor cell survival and proliferation, combined with the inhibition of cellular immunity and apoptosis in the TME, hence triggering EOC tumor progression. The gene discussed is MALAT1; the disease is cancer.